CSRXP COMMENDS ADVANCEMENT OF BILL TO BOOST AGENCY COOPERATION TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Jul 28, 2022
Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will… Read More
© 2026 CSRXP- All Rights Reserved
Updates
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE, NOVARTIS
Jul 22, 2022
Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to… Read More
CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES
Jul 19, 2022
Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma… Read More
ICYMI: USPTO, FDA ANNOUNCE PLAN TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Jul 19, 2022
Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug… Read More
CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING
Jul 12, 2022
Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While… Read More
SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION
Jul 11, 2022
PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t… Read More
BIG PHARMA WATCH: ABBVIE UTILIZED LOOPHOLES TO AVOID PAYING BILLIONS IN U.S. TAXES & FURTHER MAXIMIZE PROFITS WHILE HIKING PRICES
Jul 8, 2022
Committee Report Shows How Brand Name Drug Company Further Juiced Profits on… Read More
CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES
Jun 29, 2022
Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of… Read More
DOSE OF REALITY: PATENT HEARINGS OFFER OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE PRACTICES
Jun 22, 2022
Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives… Read More
SECOND OPINION: PHRMA REDUXES DEBUNKED BLAME GAME RHETORIC IN NEW AD CAMPAIGN
Jun 17, 2022
Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade… Read More
THEY SAID IT! ANTITRUST EXPERTS AND OFFICIALS SHINE A LIGHT ON BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK
Jun 16, 2022
Federal Trade Commission Workshop Highlights How Brand Name Drug Companies… Read More
DOSE OF REALITY: BIG PHARMA TARGETS MERGERS AND ACQUISITIONS TO KEEP PRICES HIGH, EXTEND MONOPOLIES AND BOOST PROFITS
Jun 13, 2022
FTC Workshop Can Highlight How Brand Name Drug Companies Employ… Read More